Fundamental Health Revolution

Let's start a all-round health and community care.

Together we can bring a mental health revolutions!

Lets support and spread awareness on the ground breaking research that leading scientist are doing to treat end-of-life anxiety, addiction, PTSD, and brain cognition with psychedelic assisted therapies.

The researchs we support

Fundamental researches to make a world a better place to be with a good mental health.

End-of-life Anxiety

Alcholism

PTSD

Brain Cognition

"In USA almost one out of every five U.S. adults are suffering from mental illness. (~52 Millions in 2019)"

Research on:

End-of-life anxiety

The Issue

Around 40-50% of newly-diagnosed cancer patients suffer some sort of depression or anxiety. Antidepressants have little effect, particularly on the “existential” depression that can lead some to feel their lives are meaningless, and to contemplate suicide.

The Research

Psilocybin produced significant decreases in clinician-rated and self-rated measures of depression, anxiety and mood disturbance, and increases in quality of life, death acceptance and optimism; effects sustained for at least six months.

The Future

A larger study with a more diverse population should be conducted to establish the generality and safety of psilocybin treatment of psychological distress associated with life-threatening cancer.

The Issue

Addiction to alcohol, tobacco, and other drugs is the leading preventable cause of death and disability globally; the economic costs of substance use disorders are over half a trillion dollars per year in the US alone, including factors like health care costs, lost productivity, crime, and law enforcement.

The Research

The psychedelic method, rather than emphasizing resolution of childhood conflicts or traumatic experiences, used higher doses of hallucinogens. Administered on one or a few occasions with the goal of inducing a “mystical” experience, they often induced lasting change in habitual patterns of thought, emotional response, and behavior.

The Future

Randomized-controlled trials are now in progress testing the efficacy of psilocybin-assisted treatment of various substance use disorders, and more will likely be needed.

Research on:

Alcoholism

Research on:

PTSD

(Post Traumatic Stress Disorder)

The Issue

PTSD is a debilitating anxiety disorder characterized by re-experiencing, hyperarousal and avoidance symptoms. In the US, the lifetime prevalence of PTSD in the general population is between 6% and 10%. Existing therapies for PTSD are ineffective for 25-50% of patients in clinical trials.

The Research

Preliminary studies have shown that MDMA, in conjunction with psychotherapy, can help people overcome PTSD, and possibly other disorders as well. MDMA is known for increasing feelings of trust and compassion towards others, which could make an ideal adjunct to psychotherapy for PTSD.

The Future

More studies are needed to finalize the methodology, assess the magnitude and variance of the treatment’s effect, evaluate whether the method is generalizable across patient populations and different cultures, and address questions about the therapeutic method’s mechanism of action, optimal dosing and possible refinements.

The Issue

In the last few years, the world has been waking up to the power of psychedelic micro-dosing, with a particular focus on LSD. Extensive anecdotal reports suggest that micro-dosing can improve mood, enhance cognition, increase productivity, and boost creativity.

The Research

So far, no scientific research has been done to confirm these effects.

The Future

The world’s first scientific study on the efficacy of micro-dosing, using the latest brain imaging technology, a range of validated tests and questionnaires, and will incorporate a new challenge: playing the ancient game of Go.

Research on:

Cognition & creativity

The science in the media

"A Dose of a Hallucinogen From a ‘Magic Mushroom,’ and Then Lasting Peace."

Testimonial: The experience did not restore him to his former life, he said, “but I have a greater sense of peace of what might come. I’m very grateful, beyond words, for this trial. But you have to approach the session with the right intentions of why you’re doing it. Because you’re going to meet yourself. ”


The mental health crisis

One in four Americans currently struggle with mental health, leading to over USD $400 billion in lost earnings and health care costs each year. About two thirds of those diagnosed never seek treatment.

450 million

people around the world are suffering from mental health issues.

60 million

people struggle with mental health in US alone

Current available solutions typically involve a combination of psychotherapy and pharmacotherapy. The effects vary from individual to individual, making it very difficult to gage what the current treatments actually do for patients. Until now, mental health has largely been managed through traditional treatment methods, which in many cases come with a raft of problems: treatments are expensive, bear unpleasant side effects, vary in their consistency, offer no specific completion date, and only treat the symptoms of these illnesses as opposed to the root cause.

The Mental Health Revolution

Because the substances used in psychedelic-assisted treatments are in the public domain, the compounds can not be patented. Additionally, since these treatments offer long lasting effects on patients, the model goes against traditional treatments that offer high profit from recurrent medication.

With no help from the government or pharmaceutical companies, these clinical trials must rely solely on the support of a private donors and institutions in order to complete the process toward medicalization and re-scheduling of the compounds.

Prevalence of mental illness in the U.S. by diagnosis*

Anxiety Disorders


42 Million Adults


Major Depression

16 Million Adults


Alcohol Abuse Disorder

17 Million Adults

Based on 2015 reports by the National Alliance on Mental Illness and 2012 reports by the National Institute on Alcohol Abuse and Alcoholism

We live in a society that values making a profit above our own individual and collective mental health. We have the opportunity to do something about it.

Together we can support something that will make a legitimate and significant positive impactful on society.